Table 2.

Expression of PAX2 in NSCLC

Characteristics	No. patients	PAX2 positive	P value
Gender
M	23	78.3% (18/23)	0.553
F	6	100% (6/6)
Age (Y)
≥60	18	88.9% (16/18)	0.339
<60	11	72.7% (8/11)
Histologic type
Adenocarcinoma	12	91.7% (11/12)	0.370
Squamous cellcarcinoma	17	76.5% (13/17)
Smoking
Yes	19	84.2% (16/19)	1.000
No	10	80% (8/10)
Lymph node metastasis
Positive	3	33.3% (1/3)	0.068
Negative	26	88.5% (23/26)
Stage
I+II	16	75% (12/16)	0.343
III+IV	13	92.3% (12/13)